SCHEMBL7039657

SCHEMBL7039657

COC(=O)c1ccc(C(=O)Nc2ccc(C(=O)OCc3ccccc3)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.69
GAA P10253 4/20 0.69
KMT2A Q03164 4/20 0.69
PTPN1 P18031 1/20 0.68
NPC1 O15118 7/20 0.66
SMN1; SMN2 Q16637 5/20 0.66
PKM P14618 1/20 0.65
PSMD14 O00487 1/20 0.61
CACNA1B Q00975 1/20 0.61
APBA1 Q02410 1/20 0.61
SLC6A2 P23975 1/20 0.59
SLC6A3 Q01959 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
LMNA P02545 2/20 0.59
ATM Q13315 1/20 0.58
ALDH1A1 P00352 3/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 2/20 0.58
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22388846 0.88 KMT2A (0.76) RAB9AGAAKMT2ANPC1SMN1; SMN2
SCHEMBL12348789 0.86 RAB9A (0.65) RAB9AGAAKMT2ANPC1SMN1; SMN2
SCHEMBL62930 0.85 PTPN1 (0.90) RAB9AGAAKMT2APTPN1NPC1
SCHEMBL20691188 0.84 KMT2A (0.74) RAB9AGAAKMT2ASMN1; SMN2PKM
SCHEMBL2835923 0.83 PTPN1 (0.81) RAB9AGAAKMT2APTPN1NPC1
SCHEMBL20442278 0.82 KMT2A (0.72) RAB9AGAAKMT2ANPC1SMN1; SMN2
SCHEMBL8660366 0.82 NPC1 (0.83) RAB9AKMT2APTPN1NPC1SMN1; SMN2
SCHEMBL6263820 0.82 NPC1 (0.83) RAB9AKMT2APTPN1NPC1SMN1; SMN2
Dimethyl Phthalate SCHEMBL7826081 0.81 KMT2A (0.69) RAB9AGAAKMT2ANPC1SMN1; SMN2
SCHEMBL22223650 0.81 PTPN1 (0.94) RAB9AKMT2APTPN1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289936-A1 SUBSTITUTED STILBENES AS GLUCOSE UPTAKE ENHANCERS TELIK, INC. (US) 2003-03-12 EP disclosed
US-6479548-B2 P-(BENZOYLAMINO)STILBENE DERIVATIVES TELIK, INC. 2002-11-12 US disclosed
US-20020032218-A1 Substituted stilbenes as glucose uptake enhancers TELIK, INC. 2002-03-14 US disclosed
WO-2001094295-A1 SUBSTITUTED STILBENES AS GLUCOSE UPTAKE ENHANCERS TELIK, INC. (US) 2001-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032218-A1 Substituted stilbenes as glucose uptake enhancers SLC2A1, SLC2A8, SLC2A2 RAB9A 3467/4885GAA 340/4885KMT2A 3788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.